Please login to the form below

Not currently logged in
Email:
Password:

Oasmia Pharmaceuticals

This page shows the latest Oasmia Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Going for gold

Not a smooth road In September, Sonus Pharmaceuticals revealed that it was suspending development of its new paclitaxel formulation, Tocosol Paclitaxel. ... Oasmia Pharmaceuticals is conducting a phase III clinical development with its liposomal product

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Ulf Jungnelius joins Oasmia Pharmaceuticals Dr Ulf Jungnelius joins Oasmia Pharmaceuticals

    He becomes senior medical advisor. Oasmia Pharmaceuticals has appointed Dr Ulf Jungnelius as its new senior medical advisor. ... in taking oncology blockbusters to regulatory approval and commercial success, to the Oasmia Pharmaceutical team.”.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics